化学
埃索美拉唑
辅因子
硫化物
对映体过量
核化学
药物化学
催化作用
有机化学
酶
对映选择合成
医学
解剖
作者
Na Xu,Jun Zhu,Yinqi Wu,Yan Zhang,Jianye Xia,Qian Zhao,Guo‐Qiang Lin,Hui‐Lei Yu,Jian‐He Xu
标识
DOI:10.1021/acs.oprd.0c00115
摘要
Esomeprazole is the most popular proton pump inhibitor (PPI) for treating gastroesophageal reflux disease. Enzymatic asymmetric sulfoxidation is a green approach to produce chiral sulfoxides. In this report, we focused on optimizing asymmetric sulfoxidation catalyzed by prazole sulfide monooxygenase ( Ac PSMO). The costly redox cofactor NADPH utilized by Ac PSMO was regenerated by formate dehydrogenase with CO 2 as the coproduct, which can be removed easily. During the scale-up process, oxygen supply was found to be the main limiting factor during the early phase of the reaction, while the instability of Ac PSMO and the lack of the cofactor NADPH hindered progress during the middle and late phases of the 0.6 L reaction. Finally, by adjusting oxygen mass transfer and increasing the dissolved oxygen, the enzymatic reaction was stepwise amplified to a 120 L scale using a 300 L thermostatic stirred reactor, affording 95.9% conversion and 99.9% enantiomeric excess after 12 h. Extraction and refinement of the product resulted in 0.39 kg of the isolated esomeprazole (sodium salt), with 57.8% overall yield (73.4% before the salt-forming reaction) and 99.1% purity. Thus, a green-by-design system was constructed for the efficient and precise oxidation of omeprazole sulfide into esomeprazole with molecular O 2 as the green cosubstrate and CO 2 and H 2 O as byproducts.
科研通智能强力驱动
Strongly Powered by AbleSci AI